MedPage Today) — BERLIN — Non-small cell lung cancer (NSCLC) patients starting immunotherapy were nearly twice as likely to be alive 3 years later if they got a COVID-19 vaccine around the time of treatment, a researcher reported here.
Retrospective…
Read More
About The Author
